Kendalle Burlin O’Connell is a seasoned and effective executive who has received wide acclaim for her leadership of MassBio, the world’s largest biopharma membership organization, where she drives the strategy to grow the industry and support member companies as CEO and president. To better serve the entire life cycle of biopharma companies, Kendalle has expanded MassBio’s innovation offerings to include partnering and investor events, an entrepreneurial accelerator, and a network for founders and chief executives. As part of MassBio’s commitment to realizing a more diverse and equitable life sciences industry, Kendalle was the driving force behind the organization’s launch of the non-profit Bioversity and the opening of its first workforce training center in Dorchester where graduates are prepared for rewarding entry-level careers at local life sciences companies. Kendalle has been an outspoken advocate for the industry in policy debates about state government support for the expansion of the life sciences in Massachusetts, the federal government’s intervention into biopharma innovation, and efforts to improve the affordability and accessibility of life-changing medicines, just to name a few. Kendalle has earned numerous accolades for her leadership, including top recognitions from Boston Magazine and the Boston Business Journal, and serves on the Boards of The Boston Foundation and the American Cancer Society, where she is Chair for the Eastern New England region, among others.